🛒 Shopee 蝦皮購物 — 熱門好物,點此搶購! ➔

Merck bets $334m on Korea as Asia-Pacific biopharma hub

German science and technology company Merck has opened a $334 million bioprocessing plant in Daejeon, its largest life science investment in Asia-Pacific, as it seeks to bring production closer to regional drugmakers. The company said Thursday that the 44,500-square-meter facility in Dungok, Daejeon

Merck bets $334m on Korea as Asia-Pacific biopharma hub

German science and technology company Merck has opened a $334 million bioprocessing plant in Daejeon, its largest life science investment in Asia-Pacific, as it seeks to bring production closer to regional drugmakers. The company said Thursday that the 44,500-square-meter facility in Dungok, Daejeon

原文連結:KoreaHerald

💬 留言板 — 歡迎分享你的想法!

載入留言中...